Belgium

In February 2010, the Belgian Association of Clinical Research Professionals (ACRP.be), the Belgian Association of Pharmaceutical Physicians (BeAPP), the Belgian Association of Phase... 2010-03-02

Despite a 2004-2009 compound annual growth rate (CAGR) of 1.96% in local currency terms (4.42% in US dollar terms), BMI's outlook for Belgium's patented drug market is less optimistic... 2010-02-03

Drugmaker UCB has announced that it is to exit the US's primary care market in March 2010 in order to accelerate its US transition to a purely specialty-focused biopharmaceutical... 2010-02-02

Continuing with its aim of strengthening its core over-the-counter (OTC) medicines business, Belgium-based Omega Pharma has agreed to sell its remaining 24.0% stake in medical devices... 2009-11-11

Growth in the Belgian drug market is expected to decline in 2009, with pharmaceutical expenditure calculated to increase by only 2.41% by the end of this year, compared with the 5.16%... 2009-11-04

BMI believes that the Belgian government's encouragement of prescribing generic drugs is beginning to have a real impact on the country's drug market. According to data released by... 2009-10-05

In response to recent press reports stating that Belgium's national health insurance scheme Inami would see a budget growth of approximately 10% in 2009, the agency has stated that... 2009-09-10